SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 590.07 |
Enterprise Value ($M) | 1,102.77 |
Book Value ($M) | 508.40 |
Book Value / Share | 9.38 |
Price / Book | 1.16 |
NCAV ($M) | -308.00 |
NCAV / Share | -5.68 |
Price / NCAV | -1.92 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.18 |
Return on Assets (ROA) | -0.11 |
Return on Equity (ROE) | -0.22 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.47 |
Current Ratio | 2.88 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 661.40 |
Assets | 1,477.80 |
Liabilities | 969.40 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Oak Hill Advisors Lp | 6.39 | ||
13G/A | Charles Schwab Investment Management Inc | 4.20 | -22.59 | |
13G/A | BlackRock Inc. | 3.70 | -48.72 | |
13G/A | Vanguard Group Inc | 5.73 | 12.40 | |
13G/A | State Street Corp | 2.05 | -6.10 | |
13G/A | Millennium Management Llc | 4.00 | -22.71 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
228,671 | 1,152,241 | 19.85 | |
233,898 | 1,163,320 | 20.11 | |
295,292 | 1,851,934 | 15.95 | |
416,358 | 1,476,170 | 28.21 | |
347,161 | 2,004,738 | 17.32 | |
(click for more detail) |
Similar Companies | |
---|---|
BHVN – Biohaven Ltd. | BMY – Bristol-Myers Squibb Company |
CTLT – Catalent, Inc. | ELAN – Elanco Animal Health Incorporated |
HYAC – Haymaker Acquisition Corp. 4 |
Financial data and stock pages provided by
Fintel.io